First Tracks Biotherapeutics, Inc. (TRAX)
NASDAQ: TRAX · Real-Time Price · USD
18.16
-0.84 (-4.42%)
At close: Apr 24, 2026, 4:00 PM EDT
18.20
+0.04 (0.22%)
After-hours: Apr 24, 2026, 7:57 PM EDT

TRAX Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023
Period Ending
Dec '25 Dec '24 Dec '23
Cash & Equivalents
238.2123.0835.97
Short-Term Investments
73.44262.29354.94
Cash & Short-Term Investments
311.64385.37390.9
Cash Growth
-19.13%-1.42%-
Prepaid Expenses
4.764.567.65
Total Current Assets
316.4389.93398.56
Property, Plant & Equipment
13.8916.2318.27
Long-Term Investments
-35.4727.03
Other Long-Term Assets
0.260.260.26
Total Assets
330.55441.89444.11
Accounts Payable
3.113.792.43
Accrued Expenses
25.8330.4714.02
Current Portion of Leases
2.081.931.78
Total Current Liabilities
31.0236.1818.22
Long-Term Leases
12.0314.1116.04
Total Liabilities
43.0650.334.26
Common Stock
287.51391.29410.65
Comprehensive Income & Other
-0.020.31-0.8
Shareholders' Equity
287.49391.6409.85
Total Liabilities & Equity
330.55441.89444.11
Total Debt
14.1116.0417.81
Net Cash (Debt)
297.53369.34373.09
Net Cash Growth
-19.44%-1.01%-
Working Capital
285.38353.75380.33
Tangible Book Value
287.49391.6409.85
Machinery
8.318.258.11
Leasehold Improvements
0.20.20.2
Source: S&P Global Market Intelligence. Standard template. Financial Sources.